Antigen presentation in allergic sensitization

Immunology and Cell Biology

Volumn 74, Issue 2, 1996, Pages 167-173

  Mudde, Geert C ^a   Reischl, Ilona G ^a   Corvaïa, Nathalie ^a   Hren, Andrea ^a   Poellabauer, Eva Maria ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Allergy; CD23; Fc RI; IgE mediated antigen presentation

Indexed keywords

ALLERGEN; CD23 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN E;

ALLERGY; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; HUMAN; MONOCYTE; MOUSE; NONHUMAN;

EID: 0029946708     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.23     Document Type: Article

References (52)

1. Bruijnzeel-Koomen CAFM, van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells from patients with atopic dermatitis. Arch. Dermatol. Res. 1986; 278: 199-205.
2. Kehry MR, Yamashita LC. Low-affinity IgE receptor (CD23) function on mouse B cells: Role in IgE-dependent antigen focusing. Proc. Natl Acad. Sci. USA 1989; 86: 7556-60.
3. Mudde GC, Hansel TT, Van Reijsen FC, Osterhoff BF, Bruijnzeel-Koomen CAFM. IgE: An immunoglobulin specialized in antigen capture. Immunol. Today 1990; 11: 440-3.
4. Pirron U, Schlunck T, Prinz JC, Rieber EP. IgE-dependent antigen focussing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 1990; 20: 1547-51.
5. Van der Heijden FL, Van Neerven RJJ, Van Katwijk M, Bos JD, Kapsenberg ML. Serum-IgE-facilitated allergen presentation in atopic disease. J. Immunol. 1993; 150: 3643-50.
6. Heyman B, Tianmin L, Gustavsson S. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur. J. Immunol. 1993; 23: 1739-42.
7. Santamaria LF, Bheekha R, Van Reijsen FC et al. Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum. Immunol. 1993; 37: 23-30.
8. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. Consequences for IgE/CD23 mediated antigen presentation in allergy. Immunol. Today 1995; 16: 380-3.
9. Bheekha Escura R, Wasserbauer E, Hammerschmid F, Pearce A, Kidd P, Mudde GC. Regulation and targetting of T-cell immune responses by IgE and IgG antibodies. Immunology 1995; 86: 343-50.
10. Mudde GC, Van Reijsen FC, Boland GJ, De Gast GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990; 69: 335-41.
11. Hjulström S, Landin A, Jansson L, Holmdahl R, Heyman B. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur. J. Immunol. 1995; 25: 1469-72.
12. Aubry J-P, Pochon S, Graber P, Jansen KU, Bonnefoy J-Y. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992; 358: 505-7.
13. Lecoanet-Henchoz S, Gauchat JF, Aubry JP et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995; 3: 119-25.
14. Conrad DH. Murine CD23/FcεRII. Structure and function and comparison with the human counterpart. Monogr. Allergy 1991; 29: 9-27.
15. Gould H, Sutton BJ, Edmeades R, Beavil A. CD23/FcεRII. C-type lectin membrane protein with a split personality. Monogr. Allergy 1991; 29: 28-49.
16. Stevens RH, Brieva JA, Martin RA, Saxon A. Regulation of specific antibody production via CD23. Monogr. Allergy 1991; 29: 169-77.
17. Gordon J, Cairns JA, Liu Y-J et al. Role of membrane and soluble CD23 in lymphocyte physiology. Monogr. Allergy 1991; 29: 156-68.
18. Plater-Zyberk C, Bonnefoy J-Y. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nature Medicine 1995; 1: 781-5.
19. Sarfati M, Bettler B, Letellier M et al. Native and recombinant soluble CD23 fragments with IgE suppressive activity. Immunology 1992; 76: 662-7.
20. Flores-Romo L, Shields J, Humbert Y et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 1993; 261: 1038-41.
21. Fujiwara H, Kikutani H, Suematsu S et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl Acad. Sci. USA 1994; 91: 6835-9.
22. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 1994; 179: 1109-18.
23. Reischl IG, Corvaïa N, Effenberger F, Krömer E, Wolff-Winiski B, Mudde GC. Function and regulation of FcεRI expression on monocytes of non-atopic donors. Clin. Exp. Allergy 1995 (in press).
24. Bruijnzeel-Koomen CAFM, Van der Donk EMM, Bruijnzeel PLB, Capron M, De Gast GC, Mudde GC. Associated expression of CD1 antigen and the Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin. Exp. Immunol. 1988; 74: 137-42.
25. Bieber T, De la Salle H, Wollenberg A et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J. Exp. Med. 1992; 175: 1285-90.
26. Wang B, Rieger A, Kilgus O et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J. Exp. Med. 1992; 175: 1353-65.
27. Grabbe J, Haas N, Hamann K, Kolde G, Hakimi J, Czarnetzki BM. Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br. J. Dermatol. 1993; 129: 120-3.
28. Poulter LW, Campbell DA, Munro CS, Janossy G. Discrimination of human macrophages and dendritic cells using monoclonal antibodies. Scand. J. Immunol. 1986; 24: 351-7.
29. Leung DYM, Schneeberger EE, Siraganian RP, Geha RS, Bhan AK. The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis. Clin. Immunol. Immunopathol. 1987; 42: 328-37.
30. Van Reijsen FC. Cutaneous T Cell Activation in Atopic Dermatitis. Den Haag, The Netherlands: CIP-data. Koninklijke Bibliotheek, 1995; 7.
31. Soussi Gounni A, Lamkhioued B, Ochiai K et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994; 367: 183-6.
32. Maurer D, Fiebiger E, Reininger B et al. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J. Exp. Med. 1994; 179: 745-50.
33. Louahed J, Kermouni A, Van Snick J, Renauld JC. IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J. Immunol. 1995; 154: 5061-70.
34. Jürgens M, Wollenberg A, Hanau D, De la Salle H, Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, FcεRI. J. Immunol. 1995; 155: 5184-9.
35. Maurer D, Ebner C, Reininger B et al. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J. Immunol. 1995; 154: 6285-90.
36. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. IgE mediated antigen presentation. Allergy 1995; 50: 193-9.
37. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test. J. Allergy Clin. Immunol. 1992; 89: 801-10.
38. Van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J. Allergy Clin. Immunol. 1992; 90: 184-93.
39. Kawamura T, Furue M. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: Differential regulation by T helper type 1 and T helper type 2 cytokines. Eur. J. Immunol. 1995; 25: 1913-17.
40. Van Reijsen FC, Wijburg OLC, Gebhardt M et al. Different growth factor requirements for human Th2 cells may reflect in vivo induced anergy. Clin. Exp. Immunol. 1994; 98: 151-7.
41. Scholl PR, Geha RS. Physical association between the high-affinity IgG receptor (FcγRI) and the γ subunit of the high-affinity IgE receptor (FcεRIγ). Proc: Natl Acad. Sci. USA 1993; 90: 8847-50.
42. Turner KJ, Marzo A, Holt BJ et al. Ultrastructural localisation of IgE in peripheral blood monocytes from atopies. Int. Arch. Allergy Appl. Immunol. 1988; 85: 109-12.
43. Langeveld-Wildschut EG, Van Marion AMW, Thepen T, Mudde GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Evaluation of variables influencing the outcome of the atopy patch test. J. Allergy Clin. Immunol. 1995; 96: 66-73.
44. Thepen T, Langeveld-Wildschut EG, Bihari IC et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response into a Th1 response in situ. An immuno-cytochemical study. J. Allergy Clin. Immunol. 1995; (in press).
45. Bruijnzeel-Koomen CAFM, Wichen v DF, Spry CJF, Venge P, Bruijnzeel PLB. Active participation of eosinophils in patch test reactions to inhalent allergens in patients with atopic dermatitis. Br. J. Dermatol. 1988; 118: 229-38.
46. Duncan DD, Swain SL. Role of antigen-presenting cells in the polarized development of helper T cell subsets: Evidence for differential cytokine production by ThO cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 1994; 24: 2506-14.
47. + T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 1991; 147: 8-13.
48. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 1990; 145: 3796-806.
49. Sieling PA, Wang X-H, Gately MK et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J. Immunol. 1994; 153: 3639-47.
50. Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. Arch. Dermatol. 1992; 128: 187-92.
51. Sarfati M, Vanderbeeken Y, Rubio-Trujillo M, Duncan DD, Delespesse G. Presence of IgE suppressor factors in human colostrum. Eur. J. Immunol. 1986; 16: 1005-8.
52. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: Prospective follow-up study until 17 years old. Lancet 1995; 346: 1065-9.